These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7389273)

  • 1. Plasma alpha 2HS-glycoprotein concentration in Paget's disease of bone: its possible significance.
    Ashton BA; Smith R
    Clin Sci (Lond); 1980 May; 58(5):435-8. PubMed ID: 7389273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of Paget's disease of bone with diphosphonates and calcitonin].
    Ziegler R; Holz G; Minne H; Delling G
    Verh Dtsch Ges Inn Med; 1978; (84):1122-5. PubMed ID: 741902
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of resistant Paget's disease of bone with pamidronate.
    Mallette LE
    Arch Intern Med; 1989 Dec; 149(12):2765-7. PubMed ID: 2596945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in vitamin D metabolites during treatment of Paget's disease of bone with calcitonin or etidronate.
    Devlin RD; Gutteridge DH; Prince RL; Retallack RW; Worth GK
    J Bone Miner Res; 1990 Nov; 5(11):1121-6. PubMed ID: 2125401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential treatment of Paget's disease with human calcitonin and dichloromethylene diphosphonate (Cl2MDP).
    Adami S; Guarrera G; Salvagno G; Spiazzi G; Marini G; Rosini S; Lo Cascio V
    Metab Bone Dis Relat Res; 1984; 5(6):265-7. PubMed ID: 6238218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cardiovascular system in Paget's disease of bone and the response to therapy with calcitonin and diphosphonate.
    Henley JW; Croxson RS; Ibbertson HK
    Aust N Z J Med; 1979 Aug; 9(4):390-7. PubMed ID: 292378
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of Paget's disease of bone: diphosphonates or calcitonin?].
    Davoine GA; Jung A; Courvoisier B
    Schweiz Med Wochenschr; 1981 Apr; 111(15):518-24. PubMed ID: 6785879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates.
    Alvarez L; Peris P; Guañabens N; Vidal S; Ros I; Pons F; Filella X; Monegal A; Muñoz-Gomez J; Ballesta AM
    Arthritis Rheum; 2003 Mar; 48(3):824-8. PubMed ID: 12632438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of serum osteocalcin in Paget's disease of bone and its response to diphosphonate treatment.
    Coulton LA; Preston CJ; Couch M; Kanis JA
    Arthritis Rheum; 1988 Sep; 31(9):1142-7. PubMed ID: 3048274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pain in Paget's disease: a retrospective study of treatment efficacy.
    Zati A; Colori BC; Bonfiglioli Stagni S; Mignani A
    Neuro Endocrinol Lett; 2011; 32(2):127-32. PubMed ID: 21552192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma calcitonin in Paget's disease of bone.
    Kanis JA; Heynen G; Walton RJ
    Clin Sci Mol Med; 1977 Mar; 52(3):329-32. PubMed ID: 844263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradoxical acute hypercalcemic effect of salmon calcitonin in patients having Paget's disease of bone after treatment with dichloromethylene diphosphonate.
    Delmas PD; Chapuy MC; Meunier PJ
    Horm Metab Res; 1984 May; 16(5):258-61. PubMed ID: 6234216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of the combined calcitonin and sodium etidronate therapy in Paget's disease of bone].
    Nuti R; Turchetti V; Righi G; Vattimo A
    Minerva Med; 1982 Mar; 73(9):467-72. PubMed ID: 6801555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paget's disease of bone: presentation, extent and response to bisphosphonates.
    Wang LM; Au-Yeong ML; McKenna MJ
    Ir Med J; 2002 Sep; 95(8):244, 246. PubMed ID: 12405502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitonin and diphosphonate in the treatment of Paget's disease of bone.
    Hosking DJ
    Metab Bone Dis Relat Res; 1981; 3(4-5):317-26. PubMed ID: 6820113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The acute response to calcitonin in Paget's disease: its relationship to the serum alkaline phosphatase level and the effect of phosphate treatment.
    Gershberg H; Girgis M; Goldberg L; Duga J; St Paul H
    J Clin Endocrinol Metab; 1973 Apr; 36(4):691-6. PubMed ID: 4686375
    [No Abstract]   [Full Text] [Related]  

  • 17. Paget's disease of the bone: observations after cessation of long-term synthetic salmon calcitonin treatment.
    Avramides A; Flores A; DeRose J; Wallach S
    J Clin Endocrinol Metab; 1976 Mar; 42(3):459-63. PubMed ID: 1254686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic treatment of Paget's disease of bone with synthetic human calcitonin.
    Lang R; Milkman M; Jensen PS; Vignery AM
    Yale J Biol Med; 1981; 54(5):355-65. PubMed ID: 7336766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Paget's disease of the skeleton].
    Ziegler R
    Orthopade; 1988 Sep; 17(5):407-10. PubMed ID: 3054712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of calcitonin treatment on the natural course of bone demineralization in Paget's disease.
    Toh SH; Claunch BC; Brown PH
    J Clin Endocrinol Metab; 1983 Feb; 56(2):405-9. PubMed ID: 6822644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.